Compare DERM & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | INFU |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9M | 194.8M |
| IPO Year | 2021 | 2005 |
| Metric | DERM | INFU |
|---|---|---|
| Price | $6.68 | $9.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $12.67 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 356.1K | 266.9K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.72 | ★ 181.82 |
| EPS | N/A | ★ 0.05 |
| Revenue | $61,858,000.00 | ★ $143,436,000.00 |
| Revenue This Year | $39.72 | $3.20 |
| Revenue Next Year | $63.24 | $7.31 |
| P/E Ratio | ★ N/A | $193.80 |
| Revenue Growth | ★ 10.20 | 6.36 |
| 52 Week Low | $4.31 | $5.43 |
| 52 Week High | $9.56 | $11.04 |
| Indicator | DERM | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 53.44 | 53.69 |
| Support Level | $5.80 | $8.59 |
| Resistance Level | $8.23 | $10.04 |
| Average True Range (ATR) | 0.47 | 0.48 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 56.00 | 62.72 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.